

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 7.27318999 |
| 2 | regulation of fibrinolysis (GO:0051917) | 6.66965186 |
| 3 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.86748647 |
| 4 | protein carboxylation (GO:0018214) | 5.86748647 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.40829107 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.40829107 |
| 7 | regulation of protein activation cascade (GO:2000257) | 5.18829242 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.18655337 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 5.18655337 |
| 10 | negative regulation of sterol transport (GO:0032372) | 5.17803040 |
| 11 | negative regulation of cholesterol transport (GO:0032375) | 5.17803040 |
| 12 | fibrinolysis (GO:0042730) | 5.16086639 |
| 13 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.97350430 |
| 14 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.96424499 |
| 15 | regulation of complement activation (GO:0030449) | 4.91092264 |
| 16 | urate metabolic process (GO:0046415) | 4.78073515 |
| 17 | urea metabolic process (GO:0019627) | 4.67823761 |
| 18 | regulation of plasminogen activation (GO:0010755) | 4.58651925 |
| 19 | complement activation, alternative pathway (GO:0006957) | 4.52437800 |
| 20 | DNA unwinding involved in DNA replication (GO:0006268) | 4.51530745 |
| 21 | intestinal cholesterol absorption (GO:0030299) | 4.41494287 |
| 22 | phospholipid efflux (GO:0033700) | 4.35573712 |
| 23 | blood coagulation, intrinsic pathway (GO:0007597) | 4.34661232 |
| 24 | exogenous drug catabolic process (GO:0042738) | 4.31900523 |
| 25 | plasma lipoprotein particle assembly (GO:0034377) | 4.28625019 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 4.25477658 |
| 27 | ribosomal small subunit assembly (GO:0000028) | 4.22372453 |
| 28 | urea cycle (GO:0000050) | 4.21659465 |
| 29 | drug transport (GO:0015893) | 4.14926869 |
| 30 | drug transmembrane transport (GO:0006855) | 4.12595202 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 4.07390412 |
| 32 | viral transcription (GO:0019083) | 4.05688804 |
| 33 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.05627278 |
| 34 | epoxygenase P450 pathway (GO:0019373) | 4.04663494 |
| 35 | cholesterol efflux (GO:0033344) | 3.99353413 |
| 36 | drug catabolic process (GO:0042737) | 3.98957686 |
| 37 | negative regulation of hemostasis (GO:1900047) | 3.93132046 |
| 38 | negative regulation of blood coagulation (GO:0030195) | 3.93132046 |
| 39 | translational termination (GO:0006415) | 3.93084029 |
| 40 | daunorubicin metabolic process (GO:0044597) | 3.91624113 |
| 41 | polyketide metabolic process (GO:0030638) | 3.91624113 |
| 42 | doxorubicin metabolic process (GO:0044598) | 3.91624113 |
| 43 | protein-lipid complex assembly (GO:0065005) | 3.83068729 |
| 44 | DNA strand elongation (GO:0022616) | 3.82931170 |
| 45 | DNA deamination (GO:0045006) | 3.76518968 |
| 46 | translational elongation (GO:0006414) | 3.76099677 |
| 47 | folic acid metabolic process (GO:0046655) | 3.72425845 |
| 48 | alpha-linolenic acid metabolic process (GO:0036109) | 3.71478896 |
| 49 | formation of translation preinitiation complex (GO:0001731) | 3.70604500 |
| 50 | cellular glucuronidation (GO:0052695) | 3.69016290 |
| 51 | plasma lipoprotein particle clearance (GO:0034381) | 3.68694235 |
| 52 | positive regulation of extracellular matrix organization (GO:1903055) | 3.66778243 |
| 53 | omega-hydroxylase P450 pathway (GO:0097267) | 3.65641339 |
| 54 | regulation of cholesterol homeostasis (GO:2000188) | 3.65362869 |
| 55 | positive regulation of blood coagulation (GO:0030194) | 3.62446483 |
| 56 | positive regulation of hemostasis (GO:1900048) | 3.62446483 |
| 57 | maturation of SSU-rRNA (GO:0030490) | 3.60549589 |
| 58 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.59442125 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 3.57896916 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 3.57896916 |
| 61 | macromolecular complex remodeling (GO:0034367) | 3.57896916 |
| 62 | regulation of apoptotic cell clearance (GO:2000425) | 3.57202009 |
| 63 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56786684 |
| 64 | negative regulation of coagulation (GO:0050819) | 3.56684187 |
| 65 | acute-phase response (GO:0006953) | 3.55796370 |
| 66 | translational initiation (GO:0006413) | 3.54098473 |
| 67 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.52317571 |
| 68 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51019627 |
| 69 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51019627 |
| 70 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.48308338 |
| 71 | organic cation transport (GO:0015695) | 3.47173284 |
| 72 | regulation of lipoprotein particle clearance (GO:0010984) | 3.45074812 |
| 73 | proline biosynthetic process (GO:0006561) | 3.44323479 |
| 74 | glucuronate metabolic process (GO:0019585) | 3.43721004 |
| 75 | uronic acid metabolic process (GO:0006063) | 3.43721004 |
| 76 | negative regulation of wound healing (GO:0061045) | 3.42633415 |
| 77 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.40466001 |
| 78 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.39323965 |
| 79 | positive regulation of coagulation (GO:0050820) | 3.37989234 |
| 80 | Golgi transport vesicle coating (GO:0048200) | 3.33292561 |
| 81 | COPI coating of Golgi vesicle (GO:0048205) | 3.33292561 |
| 82 | DNA replication initiation (GO:0006270) | 3.32873925 |
| 83 | cotranslational protein targeting to membrane (GO:0006613) | 3.30984345 |
| 84 | tricarboxylic acid metabolic process (GO:0072350) | 3.29698598 |
| 85 | regulation of humoral immune response (GO:0002920) | 3.29599987 |
| 86 | protein targeting to ER (GO:0045047) | 3.29283583 |
| 87 | glycine metabolic process (GO:0006544) | 3.27156975 |
| 88 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.26894833 |
| 89 | dosage compensation (GO:0007549) | 3.23705430 |
| 90 | plasma lipoprotein particle organization (GO:0071827) | 3.22617914 |
| 91 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.22341440 |
| 92 | toxin transport (GO:1901998) | 3.22323452 |
| 93 | nucleobase biosynthetic process (GO:0046112) | 3.20566820 |
| 94 | negative regulation of lipase activity (GO:0060192) | 3.19129765 |
| 95 | regulation of triglyceride catabolic process (GO:0010896) | 3.15731891 |
| 96 | viral life cycle (GO:0019058) | 3.14082536 |
| 97 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.12655513 |
| 98 | negative regulation of lipid transport (GO:0032369) | 3.12524841 |
| 99 | ethanol oxidation (GO:0006069) | 3.12022633 |
| 100 | acylglycerol homeostasis (GO:0055090) | 3.11941876 |
| 101 | triglyceride homeostasis (GO:0070328) | 3.11941876 |
| 102 | protein localization to kinetochore (GO:0034501) | 3.10961604 |
| 103 | bile acid metabolic process (GO:0008206) | 3.10887239 |
| 104 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.09709283 |
| 105 | ribosomal small subunit biogenesis (GO:0042274) | 3.08079661 |
| 106 | protein localization to endoplasmic reticulum (GO:0070972) | 3.06874412 |
| 107 | primary alcohol catabolic process (GO:0034310) | 3.06784302 |
| 108 | reverse cholesterol transport (GO:0043691) | 3.06305768 |
| 109 | protein activation cascade (GO:0072376) | 3.06061250 |
| 110 | serine family amino acid catabolic process (GO:0009071) | 3.05660727 |
| 111 | cellular protein complex disassembly (GO:0043624) | 3.04545502 |
| 112 | protein-lipid complex subunit organization (GO:0071825) | 3.04193701 |
| 113 | pentose-phosphate shunt (GO:0006098) | 3.02583959 |
| 114 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.02253609 |
| 115 | bile acid biosynthetic process (GO:0006699) | 3.01689912 |
| 116 | phosphate ion transport (GO:0006817) | 3.01067026 |
| 117 | aromatic amino acid family catabolic process (GO:0009074) | 2.99724401 |
| 118 | pseudouridine synthesis (GO:0001522) | 2.97996022 |
| 119 | glutamate metabolic process (GO:0006536) | 2.96212706 |
| 120 | modified amino acid transport (GO:0072337) | 2.95350052 |
| 121 | NADPH regeneration (GO:0006740) | 2.91468538 |
| 122 | lysine metabolic process (GO:0006553) | 2.91160678 |
| 123 | lysine catabolic process (GO:0006554) | 2.91160678 |
| 124 | telomere maintenance via telomere lengthening (GO:0010833) | 2.91054921 |
| 125 | glucose 6-phosphate metabolic process (GO:0051156) | 2.90873453 |
| 126 | DNA replication checkpoint (GO:0000076) | 2.89614760 |
| 127 | regulation of cholesterol metabolic process (GO:0090181) | 2.89524562 |
| 128 | ribosomal large subunit biogenesis (GO:0042273) | 2.88809748 |
| 129 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.88461448 |
| 130 | protein complex disassembly (GO:0043241) | 2.88293944 |
| 131 | telomere maintenance via recombination (GO:0000722) | 2.88191782 |
| 132 | ethanol metabolic process (GO:0006067) | 2.86792385 |
| 133 | drug metabolic process (GO:0017144) | 2.86775937 |
| 134 | ribosome assembly (GO:0042255) | 2.85439311 |
| 135 | IMP biosynthetic process (GO:0006188) | 2.85202503 |
| 136 | cytolysis (GO:0019835) | 2.83846103 |
| 137 | amino-acid betaine metabolic process (GO:0006577) | 2.80528132 |
| 138 | mitotic recombination (GO:0006312) | 2.80521944 |
| 139 | phenylpropanoid metabolic process (GO:0009698) | 2.80517377 |
| 140 | mitotic nuclear envelope disassembly (GO:0007077) | 2.80366453 |
| 141 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.77936215 |
| 142 | purine nucleobase biosynthetic process (GO:0009113) | 2.76456608 |
| 143 | regulation of extracellular matrix organization (GO:1903053) | 2.73591598 |
| 144 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.73379926 |
| 145 | IMP metabolic process (GO:0046040) | 2.73364861 |
| 146 | low-density lipoprotein particle remodeling (GO:0034374) | 2.72343452 |
| 147 | ribosome biogenesis (GO:0042254) | 2.71396739 |
| 148 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.71185126 |
| 149 | complement activation, classical pathway (GO:0006958) | 2.70684921 |
| 150 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.70160057 |
| 151 | mitotic metaphase plate congression (GO:0007080) | 2.69483689 |
| 152 | rRNA processing (GO:0006364) | 2.68583542 |
| 153 | peptide catabolic process (GO:0043171) | 2.67706374 |
| 154 | macromolecular complex disassembly (GO:0032984) | 2.65880606 |
| 155 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.64465703 |
| 156 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.64144066 |
| 157 | nuclear envelope disassembly (GO:0051081) | 2.62948326 |
| 158 | membrane disassembly (GO:0030397) | 2.62948326 |
| 159 | protein localization to chromosome, centromeric region (GO:0071459) | 2.61002887 |
| 160 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.59987811 |
| 161 | metaphase plate congression (GO:0051310) | 2.59876134 |
| 162 | rRNA metabolic process (GO:0016072) | 2.59305795 |
| 163 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.57624653 |
| 164 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.57619232 |
| 165 | quaternary ammonium group transport (GO:0015697) | 2.57239098 |
| 166 | negative regulation of RNA splicing (GO:0033119) | 2.56793907 |
| 167 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.56287572 |
| 168 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.55757666 |
| 169 | folic acid-containing compound metabolic process (GO:0006760) | 2.55262890 |
| 170 | folic acid transport (GO:0015884) | 2.54843749 |
| 171 | proline metabolic process (GO:0006560) | 2.54075767 |
| 172 | translation (GO:0006412) | 2.51891253 |
| 173 | galactose catabolic process (GO:0019388) | 2.50489822 |
| 174 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.50414881 |
| 175 | serine family amino acid biosynthetic process (GO:0009070) | 2.47406148 |
| 176 | establishment of integrated proviral latency (GO:0075713) | 2.46941994 |
| 177 | renal absorption (GO:0070293) | 2.46921644 |
| 178 | glyoxylate metabolic process (GO:0046487) | 2.46115095 |
| 179 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.46094968 |
| 180 | mitotic chromosome condensation (GO:0007076) | 2.45142347 |
| 181 | mRNA catabolic process (GO:0006402) | 2.44990378 |
| 182 | RNA catabolic process (GO:0006401) | 2.44884430 |
| 183 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.44467307 |
| 184 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.44065084 |
| 185 | platelet dense granule organization (GO:0060155) | 2.43811600 |
| 186 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.43175251 |
| 187 | regulation of translational fidelity (GO:0006450) | 2.40554048 |
| 188 | base-excision repair, AP site formation (GO:0006285) | 2.39822373 |
| 189 | glycoside metabolic process (GO:0016137) | 2.39244720 |
| 190 | endothelium development (GO:0003158) | 2.38952548 |
| 191 | excretion (GO:0007588) | 2.37650938 |
| 192 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.37405230 |
| 193 | negative regulation of ligase activity (GO:0051352) | 2.37405230 |
| 194 | phosphate ion transmembrane transport (GO:0035435) | 2.36862650 |
| 195 | serine family amino acid metabolic process (GO:0009069) | 2.36718726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.92234078 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.74652424 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.90545129 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.71488460 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.12079118 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.97011721 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.71126372 |
| 8 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.53768299 |
| 9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.52884211 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.42931904 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.41344668 |
| 12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.38533128 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.36154763 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.36059556 |
| 15 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.33826181 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.33700549 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.31340150 |
| 18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.30251222 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.28340050 |
| 20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.26726684 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.22193140 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.17606368 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.05455218 |
| 24 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.01762260 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.01071717 |
| 26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00828682 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.95561312 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.92972516 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92539439 |
| 30 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.90614140 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.89958339 |
| 32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.88673538 |
| 33 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.88544818 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87498111 |
| 35 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85814481 |
| 36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.85805526 |
| 37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83802156 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83205176 |
| 39 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.82839865 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.80401587 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.72014981 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63066552 |
| 43 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.62334593 |
| 44 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.58022237 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.56408491 |
| 46 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.55472760 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.55450448 |
| 48 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.55440683 |
| 49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.55356901 |
| 50 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.54232765 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53250990 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.52114172 |
| 53 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.46119182 |
| 54 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.45820909 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.45435293 |
| 56 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.45400171 |
| 57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44524802 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41795129 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41791525 |
| 60 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.40701692 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39155615 |
| 62 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.38970744 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38210244 |
| 64 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.37767403 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.36646691 |
| 66 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35732456 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34401898 |
| 68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.32949166 |
| 69 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.31888487 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29898619 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29278826 |
| 72 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29201701 |
| 73 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.29106534 |
| 74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29041667 |
| 75 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.28808241 |
| 76 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.27049229 |
| 77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26765682 |
| 78 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.26736579 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26425749 |
| 80 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26295645 |
| 81 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25880120 |
| 82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25771155 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24811483 |
| 84 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24634906 |
| 85 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23564804 |
| 86 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23248771 |
| 87 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22630103 |
| 88 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22165506 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22093133 |
| 90 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20984180 |
| 91 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.20396051 |
| 92 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.19225165 |
| 93 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.18537358 |
| 94 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18306042 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17590014 |
| 96 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16466037 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.16333481 |
| 98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16299077 |
| 99 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.16039637 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15568658 |
| 101 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15134698 |
| 102 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.14022819 |
| 103 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13880713 |
| 104 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13805507 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 1.13420691 |
| 106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13074597 |
| 107 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.11297097 |
| 108 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.10444806 |
| 109 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08566633 |
| 110 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08204780 |
| 111 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07819614 |
| 112 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07780357 |
| 113 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07523120 |
| 114 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.07234441 |
| 115 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07121298 |
| 116 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06910224 |
| 117 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06812536 |
| 118 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06796735 |
| 119 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06442982 |
| 120 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05991224 |
| 121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.05618297 |
| 122 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04530336 |
| 123 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03233543 |
| 124 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02963408 |
| 125 | MAF_26560356_Chip-Seq_TH1_Human | 1.02915310 |
| 126 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02417892 |
| 127 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02323208 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02050446 |
| 129 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01019022 |
| 130 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00936180 |
| 131 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00633396 |
| 132 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00469045 |
| 133 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00396125 |
| 134 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98420651 |
| 135 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98363927 |
| 136 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98043311 |
| 137 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97689218 |
| 138 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97207538 |
| 139 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97114726 |
| 140 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96740449 |
| 141 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.96696867 |
| 142 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95942298 |
| 143 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95808428 |
| 144 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95792778 |
| 145 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95766833 |
| 146 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95548582 |
| 147 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95471469 |
| 148 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95416666 |
| 149 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.95357920 |
| 150 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.95129754 |
| 151 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94264602 |
| 152 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.94137478 |
| 153 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.92616752 |
| 154 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92292762 |
| 155 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.90675484 |
| 156 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90039919 |
| 157 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89932066 |
| 158 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89677166 |
| 159 | P68_20966046_ChIP-Seq_HELA_Human | 0.89657681 |
| 160 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.89472620 |
| 161 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89011602 |
| 162 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88945701 |
| 163 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88273222 |
| 164 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.87411246 |
| 165 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87247050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005365_abnormal_bile_salt | 3.99933764 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 3.54790678 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.54085419 |
| 4 | MP0005360_urolithiasis | 3.13810083 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.12921855 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.09687608 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.61623283 |
| 8 | MP0003077_abnormal_cell_cycle | 2.59429885 |
| 9 | MP0001666_abnormal_nutrient_absorption | 2.58906511 |
| 10 | MP0010094_abnormal_chromosome_stability | 2.56330202 |
| 11 | MP0003252_abnormal_bile_duct | 2.42345878 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.34684398 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.29059989 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.26362492 |
| 15 | MP0000490_abnormal_crypts_of | 2.20812108 |
| 16 | MP0009643_abnormal_urine_homeostasis | 2.19910910 |
| 17 | MP0010329_abnormal_lipoprotein_level | 1.97916962 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 1.97196078 |
| 19 | MP0003878_abnormal_ear_physiology | 1.89323333 |
| 20 | MP0005377_hearing/vestibular/ear_phenot | 1.89323333 |
| 21 | MP0000609_abnormal_liver_physiology | 1.81091581 |
| 22 | MP0005332_abnormal_amino_acid | 1.80517329 |
| 23 | MP0002136_abnormal_kidney_physiology | 1.79027381 |
| 24 | MP0001730_embryonic_growth_arrest | 1.78768459 |
| 25 | MP0004264_abnormal_extraembryonic_tissu | 1.76726933 |
| 26 | MP0004043_abnormal_pH_regulation | 1.75874118 |
| 27 | MP0008932_abnormal_embryonic_tissue | 1.75496590 |
| 28 | MP0003868_abnormal_feces_composition | 1.72052159 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.71592079 |
| 30 | MP0002089_abnormal_postnatal_growth/wei | 1.69862981 |
| 31 | MP0003436_decreased_susceptibility_to | 1.69257556 |
| 32 | MP0003786_premature_aging | 1.67137992 |
| 33 | MP0003315_abnormal_perineum_morphology | 1.65892927 |
| 34 | MP0010030_abnormal_orbit_morphology | 1.60858115 |
| 35 | MP0001756_abnormal_urination | 1.57097555 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 1.54737975 |
| 37 | MP0008260_abnormal_autophagy | 1.44960687 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.43331988 |
| 39 | MP0008058_abnormal_DNA_repair | 1.42676077 |
| 40 | MP0005451_abnormal_body_composition | 1.41554822 |
| 41 | MP0009840_abnormal_foam_cell | 1.41443466 |
| 42 | MP0001697_abnormal_embryo_size | 1.41304293 |
| 43 | MP0001765_abnormal_ion_homeostasis | 1.40533414 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.39005318 |
| 45 | MP0000350_abnormal_cell_proliferation | 1.38555942 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.35458602 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.35267719 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.35267719 |
| 49 | MP0006054_spinal_hemorrhage | 1.35181353 |
| 50 | MP0003186_abnormal_redox_activity | 1.30449644 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.30125442 |
| 52 | MP0009697_abnormal_copulation | 1.29737692 |
| 53 | MP0005380_embryogenesis_phenotype | 1.28892447 |
| 54 | MP0001672_abnormal_embryogenesis/_devel | 1.28892447 |
| 55 | MP0001661_extended_life_span | 1.28491964 |
| 56 | MP0002132_abnormal_respiratory_system | 1.27047155 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.26765004 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.26696523 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.25232830 |
| 60 | MP0003984_embryonic_growth_retardation | 1.25079275 |
| 61 | MP0003718_maternal_effect | 1.24473148 |
| 62 | MP0002080_prenatal_lethality | 1.24204418 |
| 63 | MP0000685_abnormal_immune_system | 1.23947997 |
| 64 | MP0002088_abnormal_embryonic_growth/wei | 1.23890996 |
| 65 | MP0004147_increased_porphyrin_level | 1.21732257 |
| 66 | MP0002019_abnormal_tumor_incidence | 1.21227367 |
| 67 | MP0004133_heterotaxia | 1.21087130 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.20039918 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 1.19624983 |
| 70 | MP0000313_abnormal_cell_death | 1.18182836 |
| 71 | MP0003567_abnormal_fetal_cardiomyocyte | 1.15506508 |
| 72 | MP0002084_abnormal_developmental_patter | 1.15351994 |
| 73 | MP0005083_abnormal_biliary_tract | 1.14924491 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.14069078 |
| 75 | MP0004947_skin_inflammation | 1.13123939 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.13066396 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 1.12964379 |
| 78 | MP0001958_emphysema | 1.12466662 |
| 79 | MP0002139_abnormal_hepatobiliary_system | 1.11429616 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 1.10741445 |
| 81 | MP0003763_abnormal_thymus_physiology | 1.10695602 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 1.10428277 |
| 83 | MP0009278_abnormal_bone_marrow | 1.10242043 |
| 84 | MP0002085_abnormal_embryonic_tissue | 1.10222782 |
| 85 | MP0008469_abnormal_protein_level | 1.09065184 |
| 86 | MP0003566_abnormal_cell_adhesion | 1.06668999 |
| 87 | MP0002135_abnormal_kidney_morphology | 1.04718133 |
| 88 | MP0003943_abnormal_hepatobiliary_system | 1.04430511 |
| 89 | MP0001915_intracranial_hemorrhage | 1.03584336 |
| 90 | MP0005025_abnormal_response_to | 1.03518529 |
| 91 | MP0002722_abnormal_immune_system | 1.02903976 |
| 92 | MP0005220_abnormal_exocrine_pancreas | 1.02291492 |
| 93 | MP0008057_abnormal_DNA_replication | 1.02123549 |
| 94 | MP0000678_abnormal_parathyroid_gland | 1.01294441 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.99202838 |
| 96 | MP0000566_synostosis | 0.99093401 |
| 97 | MP0002796_impaired_skin_barrier | 0.98634437 |
| 98 | MP0001764_abnormal_homeostasis | 0.97909651 |
| 99 | MP0002098_abnormal_vibrissa_morphology | 0.96234764 |
| 100 | MP0000358_abnormal_cell_content/ | 0.94049625 |
| 101 | MP0008961_abnormal_basal_metabolism | 0.93848787 |
| 102 | MP0002398_abnormal_bone_marrow | 0.91759124 |
| 103 | MP0009785_altered_susceptibility_to | 0.91639090 |
| 104 | MP0001790_abnormal_immune_system | 0.90709046 |
| 105 | MP0005387_immune_system_phenotype | 0.90709046 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.89921906 |
| 107 | MP0000477_abnormal_intestine_morphology | 0.89616480 |
| 108 | MP0005408_hypopigmentation | 0.89152068 |
| 109 | MP0002429_abnormal_blood_cell | 0.87998000 |
| 110 | MP0002419_abnormal_innate_immunity | 0.87367275 |
| 111 | MP0000604_amyloidosis | 0.86000530 |
| 112 | MP0000538_abnormal_urinary_bladder | 0.85187604 |
| 113 | MP0000598_abnormal_liver_morphology | 0.83916517 |
| 114 | MP0001800_abnormal_humoral_immune | 0.83410685 |
| 115 | MP0001835_abnormal_antigen_presentation | 0.83314790 |
| 116 | MP0010307_abnormal_tumor_latency | 0.83008384 |
| 117 | MP0001853_heart_inflammation | 0.82121382 |
| 118 | MP0000703_abnormal_thymus_morphology | 0.81934851 |
| 119 | MP0005000_abnormal_immune_tolerance | 0.81716452 |
| 120 | MP0001873_stomach_inflammation | 0.80992061 |
| 121 | MP0003172_abnormal_lysosome_physiology | 0.80895938 |
| 122 | MP0004197_abnormal_fetal_growth/weight/ | 0.80656007 |
| 123 | MP0009763_increased_sensitivity_to | 0.80255797 |
| 124 | MP0008995_early_reproductive_senescence | 0.80199938 |
| 125 | MP0003806_abnormal_nucleotide_metabolis | 0.79443818 |
| 126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79334151 |
| 127 | MP0005023_abnormal_wound_healing | 0.79021370 |
| 128 | MP0005464_abnormal_platelet_physiology | 0.78704717 |
| 129 | MP0003303_peritoneal_inflammation | 0.78244288 |
| 130 | MP0005409_darkened_coat_color | 0.77815807 |
| 131 | MP0002653_abnormal_ependyma_morphology | 0.77094083 |
| 132 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76739486 |
| 133 | MP0001293_anophthalmia | 0.76735868 |
| 134 | MP0000537_abnormal_urethra_morphology | 0.76419756 |
| 135 | MP0000858_altered_metastatic_potential | 0.76082072 |
| 136 | MP0004272_abnormal_basement_membrane | 0.75823703 |
| 137 | MP0005501_abnormal_skin_physiology | 0.73112829 |
| 138 | MP0009642_abnormal_blood_homeostasis | 0.73057535 |
| 139 | MP0001845_abnormal_inflammatory_respons | 0.72779641 |
| 140 | MP0003195_calcinosis | 0.72266111 |
| 141 | MP0002970_abnormal_white_adipose | 0.71878601 |
| 142 | MP0002723_abnormal_immune_serum | 0.71579580 |
| 143 | MP0004858_abnormal_nervous_system | 0.71330666 |
| 144 | MP0005671_abnormal_response_to | 0.70205020 |
| 145 | MP0001881_abnormal_mammary_gland | 0.69866951 |
| 146 | MP0004233_abnormal_muscle_weight | 0.69351595 |
| 147 | MP0006082_CNS_inflammation | 0.68695249 |
| 148 | MP0001216_abnormal_epidermal_layer | 0.68382748 |
| 149 | MP0002111_abnormal_tail_morphology | 0.68346875 |
| 150 | MP0009053_abnormal_anal_canal | 0.67840888 |
| 151 | MP0002166_altered_tumor_susceptibility | 0.67528267 |
| 152 | MP0010155_abnormal_intestine_physiology | 0.67431642 |
| 153 | MP0009672_abnormal_birth_weight | 0.67272056 |
| 154 | MP0003183_abnormal_peptide_metabolism | 0.66614668 |
| 155 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65877757 |
| 156 | MP0001849_ear_inflammation | 0.65282010 |
| 157 | MP0010234_abnormal_vibrissa_follicle | 0.64879744 |
| 158 | MP0002420_abnormal_adaptive_immunity | 0.64162900 |
| 159 | MP0002452_abnormal_antigen_presenting | 0.63294926 |
| 160 | MP0001819_abnormal_immune_cell | 0.63269991 |
| 161 | MP0003075_altered_response_to | 0.63092783 |
| 162 | MP0000003_abnormal_adipose_tissue | 0.62539254 |
| 163 | MP0000716_abnormal_immune_system | 0.62434137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 8.59257835 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.05991603 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 5.85148303 |
| 4 | Joint hemorrhage (HP:0005261) | 5.23149942 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.08500191 |
| 6 | Increased circulating renin level (HP:0000848) | 4.86319775 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.80802514 |
| 8 | Polyuria (HP:0000103) | 4.80773899 |
| 9 | Gout (HP:0001997) | 4.68366496 |
| 10 | Reticulocytopenia (HP:0001896) | 4.64100426 |
| 11 | Complement deficiency (HP:0004431) | 4.60362154 |
| 12 | Hemorrhage of the eye (HP:0011885) | 4.49452892 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.41506990 |
| 14 | Abnormal urine output (HP:0012590) | 4.35237846 |
| 15 | Hypomagnesemia (HP:0002917) | 4.31378715 |
| 16 | Hypokalemic alkalosis (HP:0001949) | 4.25793023 |
| 17 | Hyperactive renin-angiotensin system (HP:0000841) | 4.19426029 |
| 18 | Abnormality of complement system (HP:0005339) | 4.14923957 |
| 19 | Abnormality of renal excretion (HP:0011036) | 4.11362937 |
| 20 | Abnormality of magnesium homeostasis (HP:0004921) | 4.04864601 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.94607120 |
| 22 | Abnormal drinking behavior (HP:0030082) | 3.92055563 |
| 23 | Polydipsia (HP:0001959) | 3.92055563 |
| 24 | Xanthomatosis (HP:0000991) | 3.91714391 |
| 25 | Conjugated hyperbilirubinemia (HP:0002908) | 3.82903851 |
| 26 | Metabolic alkalosis (HP:0200114) | 3.74809782 |
| 27 | Tetany (HP:0001281) | 3.69390640 |
| 28 | Proximal tubulopathy (HP:0000114) | 3.52728574 |
| 29 | Abnormality of chloride homeostasis (HP:0011422) | 3.42143331 |
| 30 | Hypercalciuria (HP:0002150) | 3.37575797 |
| 31 | IgM deficiency (HP:0002850) | 3.28362472 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.23694481 |
| 33 | Thrombocytosis (HP:0001894) | 3.23151275 |
| 34 | Increased purine levels (HP:0004368) | 3.19900178 |
| 35 | Hyperuricemia (HP:0002149) | 3.19900178 |
| 36 | Purpura (HP:0000979) | 3.18873527 |
| 37 | Glomerulonephritis (HP:0000099) | 3.03122392 |
| 38 | Renal salt wasting (HP:0000127) | 3.02500746 |
| 39 | Cholecystitis (HP:0001082) | 2.97996310 |
| 40 | Abnormal gallbladder physiology (HP:0012438) | 2.97996310 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.97567678 |
| 42 | Generalized aminoaciduria (HP:0002909) | 2.95763824 |
| 43 | Intrahepatic cholestasis (HP:0001406) | 2.87929926 |
| 44 | Vascular calcification (HP:0004934) | 2.85643984 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.80553948 |
| 46 | Hypolipoproteinemia (HP:0010981) | 2.76777943 |
| 47 | Abnormality of renin-angiotensin system (HP:0000847) | 2.75870885 |
| 48 | Menorrhagia (HP:0000132) | 2.71893076 |
| 49 | Abnormality of the Achilles tendon (HP:0005109) | 2.71706593 |
| 50 | Petechiae (HP:0000967) | 2.70747741 |
| 51 | Hyperaldosteronism (HP:0000859) | 2.70148763 |
| 52 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.68736350 |
| 53 | Hyperlipoproteinemia (HP:0010980) | 2.65985909 |
| 54 | Microretrognathia (HP:0000308) | 2.65914612 |
| 55 | Macrocytic anemia (HP:0001972) | 2.64300658 |
| 56 | Hyperglycinuria (HP:0003108) | 2.64107294 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.61076332 |
| 58 | Abnormal number of erythroid precursors (HP:0012131) | 2.54380910 |
| 59 | Abnormality of the intrinsic pathway (HP:0010989) | 2.52966137 |
| 60 | Oral leukoplakia (HP:0002745) | 2.47885239 |
| 61 | Rickets (HP:0002748) | 2.46944669 |
| 62 | Myocardial infarction (HP:0001658) | 2.46461596 |
| 63 | Alkalosis (HP:0001948) | 2.43247245 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.43145046 |
| 65 | Rough bone trabeculation (HP:0100670) | 2.42478956 |
| 66 | Gingival bleeding (HP:0000225) | 2.41127731 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.40908577 |
| 68 | Abnormality of nucleobase metabolism (HP:0010932) | 2.39242866 |
| 69 | Multiple enchondromatosis (HP:0005701) | 2.38768044 |
| 70 | Spontaneous abortion (HP:0005268) | 2.38407438 |
| 71 | Mitral stenosis (HP:0001718) | 2.34763543 |
| 72 | Colon cancer (HP:0003003) | 2.33804188 |
| 73 | Abnormal platelet function (HP:0011869) | 2.32615810 |
| 74 | Impaired platelet aggregation (HP:0003540) | 2.32615810 |
| 75 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.31788339 |
| 76 | Glycosuria (HP:0003076) | 2.31009944 |
| 77 | Abnormality of urine glucose concentration (HP:0011016) | 2.31009944 |
| 78 | Thrombophlebitis (HP:0004418) | 2.30780527 |
| 79 | Hyperphosphaturia (HP:0003109) | 2.27888039 |
| 80 | Nephritis (HP:0000123) | 2.26842537 |
| 81 | Aplastic anemia (HP:0001915) | 2.25440218 |
| 82 | Metaphyseal cupping (HP:0003021) | 2.24934541 |
| 83 | Nephrocalcinosis (HP:0000121) | 2.23462713 |
| 84 | Reticulocytosis (HP:0001923) | 2.22657745 |
| 85 | Prolonged neonatal jaundice (HP:0006579) | 2.22254987 |
| 86 | Hepatocellular carcinoma (HP:0001402) | 2.18592091 |
| 87 | Basal cell carcinoma (HP:0002671) | 2.18421490 |
| 88 | Achilles tendon contracture (HP:0001771) | 2.16068907 |
| 89 | Carpal bone hypoplasia (HP:0001498) | 2.14949036 |
| 90 | Back pain (HP:0003418) | 2.14081088 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13352884 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13352884 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13352884 |
| 94 | Flat acetabular roof (HP:0003180) | 2.12798717 |
| 95 | Mucopolysacchariduria (HP:0008155) | 2.12296101 |
| 96 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12296101 |
| 97 | Megaloblastic anemia (HP:0001889) | 2.11143095 |
| 98 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11038678 |
| 99 | Asymmetry of the thorax (HP:0001555) | 2.09657797 |
| 100 | Hyperammonemia (HP:0001987) | 2.09621584 |
| 101 | Abnormal urine phosphate concentration (HP:0012599) | 2.09109245 |
| 102 | Fat malabsorption (HP:0002630) | 2.08684381 |
| 103 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08520037 |
| 104 | Increased serum ferritin (HP:0003281) | 2.07793608 |
| 105 | Nonimmune hydrops fetalis (HP:0001790) | 2.07480426 |
| 106 | Polygenic inheritance (HP:0010982) | 2.04583411 |
| 107 | Rhabdomyosarcoma (HP:0002859) | 2.03953072 |
| 108 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.03685411 |
| 109 | Bicornuate uterus (HP:0000813) | 2.02137145 |
| 110 | Hypophosphatemic rickets (HP:0004912) | 2.00130517 |
| 111 | Pulmonary embolism (HP:0002204) | 1.99889787 |
| 112 | Nephrolithiasis (HP:0000787) | 1.99547658 |
| 113 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.99391701 |
| 114 | Abnormality of glycine metabolism (HP:0010895) | 1.99391701 |
| 115 | Renal tubular acidosis (HP:0001947) | 1.98259945 |
| 116 | Epistaxis (HP:0000421) | 1.95999861 |
| 117 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.95575935 |
| 118 | Hypokalemia (HP:0002900) | 1.93327808 |
| 119 | Gangrene (HP:0100758) | 1.93168678 |
| 120 | Pallor (HP:0000980) | 1.91690610 |
| 121 | Abnormal trabecular bone morphology (HP:0100671) | 1.91343569 |
| 122 | Delayed epiphyseal ossification (HP:0002663) | 1.90396329 |
| 123 | Abnormality of macrophages (HP:0004311) | 1.86958460 |
| 124 | Ketoacidosis (HP:0001993) | 1.86541298 |
| 125 | Seborrheic dermatitis (HP:0001051) | 1.85871252 |
| 126 | Hyperbilirubinemia (HP:0002904) | 1.85481487 |
| 127 | Hyponatremia (HP:0002902) | 1.84371847 |
| 128 | Vertebral compression fractures (HP:0002953) | 1.83083930 |
| 129 | Hypertriglyceridemia (HP:0002155) | 1.82788869 |
| 130 | High anterior hairline (HP:0009890) | 1.82711620 |
| 131 | Amaurosis fugax (HP:0100576) | 1.82474727 |
| 132 | Elevated alkaline phosphatase (HP:0003155) | 1.82468359 |
| 133 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80569054 |
| 134 | Angiofibromas (HP:0010615) | 1.80433255 |
| 135 | Adenoma sebaceum (HP:0009720) | 1.80433255 |
| 136 | Abnormal platelet volume (HP:0011876) | 1.80302712 |
| 137 | Chondrocalcinosis (HP:0000934) | 1.79335694 |
| 138 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79156100 |
| 139 | Cholelithiasis (HP:0001081) | 1.79153499 |
| 140 | Obstructive lung disease (HP:0006536) | 1.78864481 |
| 141 | Chronic obstructive pulmonary disease (HP:0006510) | 1.78864481 |
| 142 | Abnormality of glycolysis (HP:0004366) | 1.78852654 |
| 143 | Degeneration of anterior horn cells (HP:0002398) | 1.78224800 |
| 144 | Abnormality of the anterior horn cell (HP:0006802) | 1.78224800 |
| 145 | Esophageal varix (HP:0002040) | 1.77248568 |
| 146 | Abnormality of carpal bone ossification (HP:0006257) | 1.76684082 |
| 147 | Lymphangioma (HP:0100764) | 1.76508241 |
| 148 | Premature ovarian failure (HP:0008209) | 1.76350278 |
| 149 | Cervical subluxation (HP:0003308) | 1.75879114 |
| 150 | Thin bony cortex (HP:0002753) | 1.75127728 |
| 151 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.74828661 |
| 152 | Selective tooth agenesis (HP:0001592) | 1.73615419 |
| 153 | Nausea (HP:0002018) | 1.73607795 |
| 154 | Squamous cell carcinoma (HP:0002860) | 1.73586466 |
| 155 | Dicarboxylic aciduria (HP:0003215) | 1.73565852 |
| 156 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.73565852 |
| 157 | Reduced antithrombin III activity (HP:0001976) | 1.72785084 |
| 158 | Increased serum pyruvate (HP:0003542) | 1.72682671 |
| 159 | Agnosia (HP:0010524) | 1.72491624 |
| 160 | Abnormality of reticulocytes (HP:0004312) | 1.72316234 |
| 161 | Abnormal number of incisors (HP:0011064) | 1.72131766 |
| 162 | Severe short stature (HP:0003510) | 1.71670286 |
| 163 | Neoplasm of striated muscle (HP:0009728) | 1.70915752 |
| 164 | Malnutrition (HP:0004395) | 1.69509517 |
| 165 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.68493330 |
| 166 | Bifid scrotum (HP:0000048) | 1.68395005 |
| 167 | Abnormality of the lumbar spine (HP:0100712) | 1.67427519 |
| 168 | Dysostosis multiplex (HP:0000943) | 1.66896681 |
| 169 | Lower limb hyperreflexia (HP:0002395) | 1.65174516 |
| 170 | Abnormality of sodium homeostasis (HP:0010931) | 1.65138475 |
| 171 | Increased mean platelet volume (HP:0011877) | 1.65026009 |
| 172 | Pancytopenia (HP:0001876) | 1.64170090 |
| 173 | Meningitis (HP:0001287) | 1.63948602 |
| 174 | Polycythemia (HP:0001901) | 1.63313509 |
| 175 | Abnormality of iron homeostasis (HP:0011031) | 1.63197273 |
| 176 | Poikiloderma (HP:0001029) | 1.63064473 |
| 177 | Hypoalphalipoproteinemia (HP:0003233) | 1.62835632 |
| 178 | 11 pairs of ribs (HP:0000878) | 1.62519856 |
| 179 | Ependymoma (HP:0002888) | 1.62316052 |
| 180 | Abnormal tarsal ossification (HP:0008369) | 1.61929052 |
| 181 | J-shaped sella turcica (HP:0002680) | 1.61730741 |
| 182 | Steatorrhea (HP:0002570) | 1.60594748 |
| 183 | Abnormality of the thoracic spine (HP:0100711) | 1.60456331 |
| 184 | Abnormality of the nasal mucosa (HP:0000433) | 1.59257003 |
| 185 | Arterial thrombosis (HP:0004420) | 1.59067490 |
| 186 | Type I transferrin isoform profile (HP:0003642) | 1.58931654 |
| 187 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.57184803 |
| 188 | Hypochromic anemia (HP:0001931) | 1.56377408 |
| 189 | Gastrointestinal infarctions (HP:0005244) | 1.56207051 |
| 190 | Abnormal gallbladder morphology (HP:0012437) | 1.56190935 |
| 191 | Hypophosphatemia (HP:0002148) | 1.56131009 |
| 192 | Ureteral stenosis (HP:0000071) | 1.55380119 |
| 193 | Thoracic kyphosis (HP:0002942) | 1.54741656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.20039514 |
| 2 | SMG1 | 3.91963805 |
| 3 | ACVR1B | 3.45932836 |
| 4 | FGFR4 | 3.36120476 |
| 5 | WEE1 | 2.92952591 |
| 6 | BUB1 | 2.78993025 |
| 7 | TGFBR1 | 2.76774885 |
| 8 | ICK | 2.61306175 |
| 9 | SIK1 | 2.56517314 |
| 10 | WNK4 | 2.55936032 |
| 11 | IRAK3 | 2.53072462 |
| 12 | PRPF4B | 2.52076113 |
| 13 | EPHA2 | 2.45156447 |
| 14 | WNK3 | 2.26844003 |
| 15 | EEF2K | 2.25566655 |
| 16 | KDR | 2.18486765 |
| 17 | MAP4K1 | 2.11671561 |
| 18 | NME2 | 2.11481557 |
| 19 | PASK | 2.01750852 |
| 20 | NEK1 | 1.93673179 |
| 21 | EIF2AK1 | 1.93059347 |
| 22 | PAK4 | 1.84906640 |
| 23 | OXSR1 | 1.83829133 |
| 24 | DYRK3 | 1.81115852 |
| 25 | CDC7 | 1.69699982 |
| 26 | SRPK1 | 1.69203313 |
| 27 | TESK1 | 1.67572562 |
| 28 | MST1R | 1.66157628 |
| 29 | STK10 | 1.65987651 |
| 30 | LRRK2 | 1.65831530 |
| 31 | PIM2 | 1.63441901 |
| 32 | RIPK1 | 1.62686131 |
| 33 | TSSK6 | 1.62406833 |
| 34 | KIT | 1.58949075 |
| 35 | ERN1 | 1.58821659 |
| 36 | FLT3 | 1.54984996 |
| 37 | TTK | 1.54949534 |
| 38 | SCYL2 | 1.54670146 |
| 39 | TESK2 | 1.45959529 |
| 40 | BCKDK | 1.45759900 |
| 41 | TGFBR2 | 1.43513173 |
| 42 | NEK2 | 1.41819363 |
| 43 | MAP3K3 | 1.37322924 |
| 44 | MKNK1 | 1.32091861 |
| 45 | MAP3K14 | 1.30795541 |
| 46 | CDK7 | 1.30091016 |
| 47 | STK16 | 1.23495293 |
| 48 | TAOK2 | 1.22102685 |
| 49 | BTK | 1.20631831 |
| 50 | RPS6KB2 | 1.20601688 |
| 51 | MAPKAPK3 | 1.15667922 |
| 52 | IRAK4 | 1.14642164 |
| 53 | CDK4 | 1.14049078 |
| 54 | TEC | 1.14005891 |
| 55 | VRK2 | 1.13936360 |
| 56 | PKN2 | 1.11888055 |
| 57 | MAP3K8 | 1.11095272 |
| 58 | BRSK2 | 1.10404246 |
| 59 | MAP3K11 | 1.08307524 |
| 60 | MAP3K13 | 1.07970612 |
| 61 | RPS6KA4 | 1.06830954 |
| 62 | VRK1 | 1.04729595 |
| 63 | TYK2 | 1.04607562 |
| 64 | PLK4 | 1.04103958 |
| 65 | PDGFRA | 1.04065246 |
| 66 | BLK | 1.03959618 |
| 67 | CSF1R | 1.02655000 |
| 68 | PLK1 | 1.02006477 |
| 69 | RIPK4 | 1.01733604 |
| 70 | TAOK1 | 1.00784571 |
| 71 | ATR | 1.00367981 |
| 72 | PIM1 | 0.97285034 |
| 73 | AURKB | 0.96112989 |
| 74 | MAP3K6 | 0.95628245 |
| 75 | MAP2K3 | 0.94411446 |
| 76 | ZAP70 | 0.92636496 |
| 77 | JAK3 | 0.91907613 |
| 78 | PDPK1 | 0.90600712 |
| 79 | EPHB1 | 0.90326173 |
| 80 | FGFR3 | 0.86493017 |
| 81 | CSK | 0.85607946 |
| 82 | AURKA | 0.84485783 |
| 83 | MKNK2 | 0.82955512 |
| 84 | MAP3K1 | 0.81144595 |
| 85 | MAP3K10 | 0.80022643 |
| 86 | TXK | 0.76053389 |
| 87 | AKT2 | 0.75596876 |
| 88 | CDK12 | 0.75240625 |
| 89 | MAP2K2 | 0.74086538 |
| 90 | CDK9 | 0.73583701 |
| 91 | TNK2 | 0.71567056 |
| 92 | KSR2 | 0.70981371 |
| 93 | NEK9 | 0.70606077 |
| 94 | STK4 | 0.69718310 |
| 95 | MATK | 0.68960903 |
| 96 | TLK1 | 0.68193793 |
| 97 | PRKD2 | 0.66794167 |
| 98 | CHEK2 | 0.64256639 |
| 99 | MET | 0.62592899 |
| 100 | MAP2K6 | 0.60952184 |
| 101 | CDC42BPA | 0.60610198 |
| 102 | PDK1 | 0.60488816 |
| 103 | TBK1 | 0.60021275 |
| 104 | TRIB3 | 0.57632993 |
| 105 | GRK6 | 0.54513086 |
| 106 | BRSK1 | 0.53179553 |
| 107 | CDK8 | 0.53165208 |
| 108 | EIF2AK3 | 0.52718097 |
| 109 | PAK1 | 0.50598644 |
| 110 | PTK6 | 0.50235422 |
| 111 | BRD4 | 0.49391493 |
| 112 | DYRK1B | 0.49347477 |
| 113 | CHEK1 | 0.48379160 |
| 114 | RET | 0.48079946 |
| 115 | MAPKAPK2 | 0.47614873 |
| 116 | IRAK2 | 0.46922509 |
| 117 | LATS1 | 0.46258035 |
| 118 | PTK2 | 0.43857708 |
| 119 | CHUK | 0.43541902 |
| 120 | IKBKE | 0.43359076 |
| 121 | GRK1 | 0.43323297 |
| 122 | MELK | 0.42492278 |
| 123 | CDK6 | 0.41916815 |
| 124 | IKBKB | 0.41644720 |
| 125 | LATS2 | 0.41205267 |
| 126 | SIK3 | 0.38527549 |
| 127 | PRKCI | 0.37855089 |
| 128 | MOS | 0.37355583 |
| 129 | LCK | 0.37303460 |
| 130 | CDK2 | 0.35949611 |
| 131 | ARAF | 0.35308548 |
| 132 | STK38L | 0.35134336 |
| 133 | FGR | 0.34945335 |
| 134 | BRAF | 0.34923856 |
| 135 | PRKG2 | 0.34734977 |
| 136 | MTOR | 0.34483439 |
| 137 | ITK | 0.34379258 |
| 138 | CCNB1 | 0.33868694 |
| 139 | CDK19 | 0.31625457 |
| 140 | CAMK1D | 0.31152287 |
| 141 | PRKAA2 | 0.31052058 |
| 142 | ABL2 | 0.30639410 |
| 143 | BMX | 0.30329042 |
| 144 | SYK | 0.29069009 |
| 145 | LMTK2 | 0.28095695 |
| 146 | CSNK2A2 | 0.28069367 |
| 147 | MARK2 | 0.27405769 |
| 148 | ILK | 0.26487519 |
| 149 | MAPK11 | 0.26475824 |
| 150 | TTN | 0.26296973 |
| 151 | DAPK1 | 0.25929481 |
| 152 | CSNK2A1 | 0.25912567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.19202583 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.16320102 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.76497309 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.17109529 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.98679331 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.85386578 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.71477201 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.69605359 |
| 9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.49884743 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.47889979 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.47401702 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.46361028 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.16516853 |
| 14 | Retinol metabolism_Homo sapiens_hsa00830 | 2.15749424 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 2.08241887 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 2.06796701 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.03474843 |
| 18 | RNA transport_Homo sapiens_hsa03013 | 1.96720915 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.96572351 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 1.96035214 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95990883 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.95639838 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95299045 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.93660463 |
| 25 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.91800884 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91687094 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.88375749 |
| 28 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.84213468 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79731917 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.76367751 |
| 31 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.61234268 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.61041495 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.59004270 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.51758116 |
| 35 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.46761153 |
| 36 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.42325334 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41860577 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40072100 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.39417599 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.37590302 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35899542 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33710576 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32438478 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31431649 |
| 45 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.29969151 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29772926 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28350802 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27710528 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25469704 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21692120 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21318844 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 1.21216859 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18436568 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.16116128 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.14513418 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 1.09612214 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04730571 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 1.04391545 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.03919704 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03326731 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02137643 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02033934 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.00916877 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.99592055 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.99403434 |
| 66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.99231338 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94308258 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91080739 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.90793015 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90304128 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89127961 |
| 72 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88860643 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88770192 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88444574 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87314734 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86207797 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84238154 |
| 78 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82028085 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81842046 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.81143932 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79236833 |
| 82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78937688 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78396582 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78007220 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.77539064 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76468989 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.73856528 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.72337960 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71266375 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.69901756 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.66734042 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64134642 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.62754302 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61732811 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60775751 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58223955 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56731045 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.55079995 |
| 99 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54574924 |
| 100 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54302010 |
| 101 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54157673 |
| 102 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53506970 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.53376055 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50859411 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48374940 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.46900848 |
| 107 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46370861 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45631109 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45253622 |
| 110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45190045 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44468043 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.43587106 |
| 113 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42851299 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42528428 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41451801 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41195331 |
| 117 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39340726 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39254664 |
| 119 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38774208 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38747890 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37895952 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.37500077 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37420322 |
| 124 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36992736 |
| 125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35519668 |
| 126 | Protein export_Homo sapiens_hsa03060 | 0.31749336 |
| 127 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.31440371 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.30946811 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30945626 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30226299 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.30221437 |
| 132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27938248 |
| 133 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26330349 |
| 134 | Mineral absorption_Homo sapiens_hsa04978 | 0.25528410 |
| 135 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.25457178 |
| 136 | Measles_Homo sapiens_hsa05162 | 0.25204718 |
| 137 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.25188512 |
| 138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.24933698 |
| 139 | Leishmaniasis_Homo sapiens_hsa05140 | 0.24819515 |
| 140 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.24585233 |
| 141 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24337160 |
| 142 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23184250 |
| 143 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.23146371 |
| 144 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23007213 |
| 145 | Colorectal cancer_Homo sapiens_hsa05210 | 0.22258078 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21818196 |
| 147 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21280827 |
| 148 | Salmonella infection_Homo sapiens_hsa05132 | 0.18893341 |

